Exercise and nutrition interventions for sarcopenia in cirrhosis: a systematic review and network meta-analysis of randomized controlled trials
Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650–66. https://doi.org/10.1016/j.cgh.2019.07.060.
Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharm Ther. 2020;51:64–77. https://doi.org/10.1111/apt.15571.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
Dhaliwal A, Armstrong MJ. Sarcopenia in cirrhosis: a practical overview. Clin Med. 2020;20:489–92. https://doi.org/10.7861/clinmed.2020-0089.
Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLOS ONE. 2017;12:e0186990. https://doi.org/10.1371/journal.pone.0186990.
Merli M, Berzigotti A, Zelber-Sagi S, Dasarathy S, Montagnese S, Genton L, et al. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172–93.
Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020;39:3533–62.
Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–44. https://doi.org/10.1002/hep.32049.
Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality?. J Int Soc Sports Nutr. 2017;14:30. https://doi.org/10.1186/s12970-017-0184-9.
Tajiri K, Shimizu Y. Branched-chain amino acids in liver diseases. Transl Gastroenterol Hepatol. 2018;3:47. https://doi.org/10.21037/tgh.2018.07.06.
Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–84. https://doi.org/10.7326/M14-2385.
Senn SS. Cross-over trials in clinical research. John Wiley & Sons; 2002.
Suzuki K, Endo R, Kohgo Y, Ohtake T, Ueno Y, Kato A, et al. Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. Hepatol Res. 2012;42:621–6. https://doi.org/10.1111/j.1872-034X.2012.00990.x.
Bohannon RW. Considerations and practical options for measuring muscle strength: a narrative review. BioMed Res Int. 2019;2019:8194537.
Manini TM, Visser M, Won-Park S, Patel KV, Strotmeyer ES, Chen H, et al. Knee extension strength cutpoints for maintaining mobility. J Am Geriatrics Soc. 2007;55:451–7.
Hari A. Muscular abnormalities in liver cirrhosis. World J Gastroenterol. 2021;27:4862–78. https://doi.org/10.3748/wjg.v27.i29.4862.
Chen HW, Ferrando A, White MG, Dennis RA, Xie J, Pauly M, et al. Home-based physical activity and diet intervention to improve physical function in advanced liver disease: a randomized pilot trial. Dig Dis Sci. 2020;65:3350–9. https://doi.org/10.1007/s10620-019-06034-2.
Laboratories ACoPSfCPF. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–7.
Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatrics Soc. 1991;39:142–8.
Van Kan GA, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009;13:881–9. https://doi.org/10.1007/s12603-009-0246-z.
Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38:485–521. https://doi.org/10.1016/j.clnu.2018.12.022.
Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLOS Med. 2020;17:e1003082. https://doi.org/10.1371/journal.pmed.1003082.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153–60. https://doi.org/10.1136/ebmental-2019-300117.
Rücker G, König J, Krahn U, Efthimiou O, Davies A, Papakonstantinou T, et al. Package ‘netmeta’. Network meta-analysis using frequentist methods. netmeta.
Dias S, Caldwell DM. Network meta-analysis explained. Arch Dis Child—Fetal Neonatal Ed. 2019;104:F8. https://doi.org/10.1136/archdischild-2018-315224.
Rücker G, Petropoulou M, Schwarzer G. Network meta-analysis of multicomponent interventions. Biometrical J. 2020;62:808–21. https://doi.org/10.1002/bimj.201800167.
Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. Bmj. 2013;346:e8668. https://doi.org/10.1136/bmj.e8668.
Les I, Doval E, García-Martínez R, Planas M, Cárdenas G, Gómez P, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol. 2011;106:1081–8. https://doi.org/10.1038/ajg.2011.9.
Aamann L, Dam G, Borre M, Drljevic-Nielsen A, Overgaard K, Andersen H, et al. Resistance training increases muscle strength and muscle size in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2020;18:1179–87.e6. https://doi.org/10.1016/j.cgh.2019.07.058.
Lattanzi B, Bruni A, Di Cola S, Molfino A, De Santis A, Muscaritoli M, et al. The effects of 12-week beta-hydroxy-beta-methylbutyrate supplementation in patients with liver cirrhosis: results from a randomized controlled single-blind pilot study. Nutrients. 2021;13. https://doi.org/10.3390/nu13072296.
Singh Tejavath A, Mathur A, Nathiya D, Singh P, Raj P, Suman S, et al. Impact of branched chain amino acid on muscle mass, muscle strength, physical performance, combined survival, and maintenance of liver function changes in laboratory and prognostic markers on sarcopenic patients with liver cirrhosis (BCAAS Study): a randomized clinical trial. Front Nutr. 2021;8:715795. https://doi.org/10.3389/fnut.2021.715795.
Mohta S, Anand A, Sharma S, Qamar S, Agarwal S, Gunjan D, et al. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia. Hepatol Int. 2022;16:680–90. https://doi.org/10.1007/s12072-022-10334-7.
Sirisunhirun P, Bandidniyamanon W, Jrerattakon Y, Muangsomboon K, Pramyothin P, Nimanong S, et al. Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial. BMC Gastroenterol. 2022;22:66. https://doi.org/10.1186/s12876-022-02147-7.
Román E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–75. https://doi.org/10.1007/s10620-014-3086-6.
Román E, García-Galcerán C, Torrades T, Herrera S, Marín A, Doñate M, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS One. 2016;11:e0151652. https://doi.org/10.1371/journal.pone.0151652.
Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–6.e2. https://doi.org/10.1016/j.cgh.2014.04.016.
Kruger C, McNeely ML, Bailey RJ, Yavari M, Abraldes JG, Carbonneau M, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99. https://doi.org/10.1038/s41598-017-18320-y.
Simko V. Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease. Nutr Rep Int. 1983;27:765–73.
Tangkijvanich P, Mahachai V, Wittayalertpanya S, Ariyawongsopon V, Isarasena S. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients. Southeast Asian J Trop Med Public Health. 2000;31:152–7.
Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124:1792–801. https://doi.org/10.1016/s0016-5085(03)00323-8.
Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23:113–20. https://doi.org/10.1016/j.nut.2006.10.008.
Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, et al. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis. J Gastroenterol Hepatol. 2012;27:813–22. https://doi.org/10.1111/j.1440-1746.2011.07043.x.
Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, Román-Calleja BM, Méndez-Guerrero O, Rodríguez-Córdova P, et al. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Rev Gastroenterol Mex (Engl Ed). 2018;83:9–15. https://doi.org/10.1016/j.rgmx.2017.02.005.
Hernández-Conde M, Llop E, Gómez-Pimpollo L, Fernández Carrillo C, Rodríguez L, Van Den Brule E, et al. Adding branched-chain amino acids to an enhanced standard-of-care treatment improves muscle mass of cirrhotic patients with sarcopenia: a placebo-controlled trial. Am J Gastroenterol. 2021;116:2241–9. https://doi.org/10.14309/ajg.0000000000001301.
Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol. 2016;14:454–60.e3. https://doi.org/10.1016/j.cgh.2015.09.028.
Sobhy E, Kamal MM, Saad Y, Saleh DA, Elgohary R, Hassan MS. Effect of branched-chain amino acid supplementation and exercise on quadriceps muscle quantity and quality in patients with cirrhosis as assessed by ultrasonography: a randomized controlled trial. Clin Nutr ESPEN. 2024;61:108–18. https://doi.org/10.1016/j.clnesp.2024.03.011.
Hey P, Hoermann R, Sinclair M, Chapman B, Testro A, Apostolov R, et al. Branched-chain amino acid supplementation does not improve measures of sarcopenia in cirrhosis: results of a randomised controlled trial. Alimentary Pharm Therapeutics. 2024;59:941–52. https://doi.org/10.1111/apt.17917.
Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U, et al. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: a randomized clinical trial. J Gastroenterol Hepatol. 2023;38:210–8. https://doi.org/10.1111/jgh.16035.
Siramolpiwat S, Limthanetkul N, Pornthisarn B, Vilaichone R-k, Chonprasertsuk S, Bhanthumkomol P, et al. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial. BMC Gastroenterol. 2023;23:154. https://doi.org/10.1186/s12876-023-02789-1.
Higgins JP, Altman DG. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions: Cochrane Book Series. 2008:187–241.
Tipton KD, Wolfe RR. Exercise, protein metabolism, and muscle growth. Int J Sport Nutr Exerc Metab. 2001;11:109–32. https://doi.org/10.1123/ijsnem.11.1.109.
Fujita S, Volpi E. Amino acids and muscle loss with aging. J Nutr. 2006;136:277S–80S. https://doi.org/10.1093/jn/136.1.277S.
Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. Anal Biochem. 2022;647:114581. https://doi.org/10.1016/j.ab.2022.114581.
Chu SF, Liou TH, Chen HC, Huang SW, Liao CD. Relative efficacy of weight management, exercise, and combined treatment for muscle mass and physical sarcopenia indices in adults with overweight or obesity and osteoarthritis: a network meta-analysis of randomized controlled trials. Nutrients. 2021;13. https://doi.org/10.3390/nu13061992.
Negm AM, Lee J, Hamidian R, Jones CA, Khadaroo RG. Management of sarcopenia: a network meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2022;23:707–14. https://doi.org/10.1016/j.jamda.2022.01.057.
Meyer F, Bannert K, Wiese M, Esau S, Sautter LF, Ehlers L, et al. Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis. Int J Mol Sci 2020;21. https://doi.org/10.3390/ijms21155357.
EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70:172-93. https://doi.org/10.1016/j.jhep.2018.06.024.
Schwarzer G, Carpenter JR, Rücker G. Small-study effects in meta-analysis. In: Schwarzer G, Carpenter JR, Rücker G, editors. Meta-Analysis with R, Cham: Springer International Publishing; 2015, p. 107–41. https://doi.org/10.1007/978-3-319-21416-0_5.
Suchomel TJ, Nimphius S, Stone MH. The importance of muscular strength in athletic performance. Sports Med. 2016;46:1419–49. https://doi.org/10.1007/s40279-016-0486-0.
Tandon P, Ismond KP, Riess K, Duarte-Rojo A, Al-Judaibi B, Dunn MA, et al. Exercise in cirrhosis: translating evidence and experience to practice. J Hepatol. 2018;69:1164–77. https://doi.org/10.1016/j.jhep.2018.06.017.
Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J American Med Directors Assoc. 2020;21. https://doi.org/10.1016/j.jamda.2019.12.012.
Source link
Share this article: